## 

## 

## 

## 

## 



## 

## 

||Page|
|---|---|
|Trustees' report|1 -2|
|Independent auditor's report|**3-6**|
|Statement of financial activities|7|
|Balance sheet|8|
|Notes to the financial statements|10-14|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

|||**Unrestricted**|
|---|---|---|
|||**funds**|
|||**2022**|
||**Notes**|**£**|
|**Income** **from:**|||
|Donations and legacies|**3**|**1,000,000**|
|**Expenditure** **on:**|||
|Charitable activities|4|3,000|
|Net gains/(losses) on investments|**7**|(62,183)|
|**Net** **movement** **in** **funds**||934,817|
|Fund balances at 9 November 2020|||
|**Fund** **balances** **at** **5** **April** **2022**||934,817|





## 

## 

## 

|||2022||
|---|---|---|---|
||Notes|£|£|
|Fixed assets||||
|Investments|8||937,817|
|Current assets||||
|Creditors: amounts falling due within one year|9|(3,000)||
|Net current liabilities|||(3,000)|
|Total assets lesscurrent liabilities|||934,817|
|Income funds||||
|Unrestricted funds|||934,817|
||||934,817|





## 

## 

## 

|||2022||
|---|---|---|---|
|Notes|£||£|
|Cash flows from operating activities||||
|Net cash used in investing activities||||
|Net cash used in financing activities||||
|Net increase in cash and cash equivalents||||
|Cash and cash equivalents at beginning of Period||||
|Cash and cash equivalents at end of Period||||





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

||**Unrestricted**|
|---|---|
||**funds**|
||**2022**|
||**£**|
|Legacies receivable|1,000,000|





## 

## 

## 

## 

## 

## 

|**2022**||
|---|---|
|**Number**|**Number**|



||**Unrestricted**|
|---|---|
||**funds**|
||**2022**|
||**£**|
|Revaluation gain/(loss) of investments debtor|(60,703)|
|Realised gain/(ioss) on sale of investments|(1,480)|
||(62,183)|





## 

## 

|**8**|**Fixed** **asset** **investments**|||(Continued)|
|---|---|---|---|---|
|||**Investment**|**Cash** **in**|**Total**|
|||**portfolio**|**portfolio**||
|||**£**||**£**|
||**Cost** **or** **valuation**||||
||At 9 November 2020||||
||Additions|1,000,000||1,000,000|
||Valuation changes|(60,703)||(60,703)|
||Proceeds held by investment manager||25,856|25,856|
||Disposals|(27,336)||(27,336)|
||At 5 April 2022|911,961|25,856|937,817|
||**Carrying** **amount**||||
||At 05 April 2022|911,961|25,856|937,817|
||At 9 November 2020||||
|**9**|**Creditors:** **amounts** **falling** **due** **within** **one** **year**||||
|||||**2022**|
|||||**£**|
||Accruals|||3,000|
|**10**|**Analysis** **of** **net** **assets** **between** **funds**||||
|||||**Unrestricted**|
|||||**funds**|
|||||**2022**|
|||||**£**|
||Fund balances at 5 April 2022 are represented by:||||
||Investments|||937,817|
||Current assets/(liabilities)|||(3,000)|
|||||934,817|



## 

## 



## 

## 

|**13**|**Cash** **generated** **from** **operations**|**2022**|
|---|---|---|
|||£|
||Surplus for the Period|934,817|
||Adjustments for:||
||Non cash donation|(1,000,000)|
||Loss on disposal of investments|1,480|
||Fair value gains and losses on investments|60,703|
||Movements in working capital:||
||Increase in creditors|3,000|
||Cash absorbed by operations||